Amgen (NASDAQ:AMGN) will host a webcasted call for the investment community at 5 a.m. PT on Tuesday, Nov. 26, 2024, to ...

The results shed light on how MariTide may measure up to weight loss injections from Novo Nordisk and Eli Lilly and other ...

Amgen (NASDAQ:AMGN) today announced positive data at 52 weeks in a double-blind, dose-ranging Phase 2 study with MariTide ...

Amgen Inc. lost requests for several judgments in Lindis Biotech GmbH’s patent-infringement lawsuit seeking damages for sales of the leukemia treatment Blincyto, according to a federal judge’s mixed ...

The stocks of companies that make the new class of drugs to treat obesity and manage diabetes were higher across the board ...

CVS Caremark has removed several therapies to treat patients with diabetes in favor of newer products and generics, and is ...

Truist Financial analyst Srikripa Devarakonda maintained a Buy rating on Scholar Rock Holding (SRRK – Research Report) today and set a price ...

For instance, companies like Amgen are utilizing continuous manufacturing techniques that streamline production processes, reduce costs, and improve product consistency. Continuous manufacturing ...

Paltusotine can alleviate symptoms of carcinoid syndrome in patients with neuroendocrine tumors, a phase 2 study suggests.

GLP-1 receptor agonists were originally developed for the treatment of type 2 diabetes, and later of obesity, but there is growing evidence that their benefits extend far beyond reductions in blood ...

Cal Lutheran School of Management held a fireside chat with President and COO of the Jim Henson Co, Chris Lytton.

Trump Vows to Hit Mexico, Canada and China With Tariff on Day 1 President-elect Trump promised a 25 percent tariff on Canada and Mexico, and an additional 10 percent on China, blaming the flow of ...